Cargando…

Cardiovascular Profile of South African Adults with Low-Level Viremia during Antiretroviral Therapy

Chronic inflammation is an HIV infection feature, contributing to elevated risk of cardiovascular disease among people with HIV, which can be induced by viral replication. A proportion of antiretroviral therapy (ART) recipients fail to achieve viral suppression, despite not meeting criteria for trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Botha-Le Roux, Shani, Elvstam, Olof, De Boever, Patrick, Goswami, Nandu, Magnusson, Martin, Nilsson, Peter M., Strijdom, Hans, Björkman, Per, Fourie, Carla M. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144153/ https://www.ncbi.nlm.nih.gov/pubmed/35628937 http://dx.doi.org/10.3390/jcm11102812

Ejemplares similares

Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment
por: Elvstam, Olof, et al.
Publicado: (2017)

Vascular function and cardiovascular risk in a HIV infected and HIV free cohort of African ancestry: baseline profile, rationale and methods of the longitudinal EndoAfrica-NWU study
por: Fourie, Carla M. T., et al.
Publicado: (2020)

Relationship between Endothelial Function, Antiretroviral Treatment and Cardiovascular Risk Factors in HIV Patients of African Descent in South Africa: A Cross-Sectional Study
por: Nkeh-Chungag, Benedicta N., et al.
Publicado: (2021)

Age-related differences in the vascular function and structure of South Africans living with HIV
por: Louwrens, Anisca, et al.
Publicado: (2022)

HIV and Antiretroviral Therapy Are Independently Associated with Cardiometabolic Variables and Cardiac Electrical Activity in Adults from the Western Cape Region of South Africa
por: Williams, Cassidy, et al.
Publicado: (2021)

Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort
por: Elvstam, Olof, et al.
Publicado: (2022)

All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study
por: Elvstam, Olof, et al.
Publicado: (2020)

Treatment with a fixed dose combination antiretroviral therapy drug containing tenofovir, emtricitabine and efavirenz is associated with cardioprotection in high calorie diet-induced obese rats
por: Everson, Frans, et al.
Publicado: (2018)

Personal NO(2) and Volatile Organic Compounds Exposure Levels are Associated with Markers of Cardiovascular Risk in Women in the Cape Town Region of South Africa
por: Everson, Frans, et al.
Publicado: (2019)

Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy: A Swedish observational study
por: Brattgård, Hanna, et al.
Publicado: (2022)

Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans
por: Lukhwareni, Azwidowi, et al.
Publicado: (2020)

Prognostic values of modifiable risk factors for cardiovascular events in South African health promotion
por: Kganakga, Jacobeth T., et al.
Publicado: (2022)

Associations Between Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid Levels and Incidence of Invasive Cancer in People With HIV After Initiation of Combination Antiretroviral Therapy
por: Elvstam, Olof, et al.
Publicado: (2021)

Cardiovascular Risk Factors and Their Relationship with Vascular Dysfunction in South African Children of African Ancestry
por: Matjuda, Edna N., et al.
Publicado: (2021)

Cardiovascular risk and endothelial function in people living with HIV/AIDS: design of the multi-site, longitudinal EndoAfrica study in the Western Cape Province of South Africa
por: Strijdom, Hans, et al.
Publicado: (2017)

HIV infection and cardiovascular risk in black South Africans
por: Fourie, CMT, et al.
Publicado: (2011)

Predictors of Viremia in Postpartum Women on Antiretroviral Therapy
por: Hoffman, Risa M., et al.
Publicado: (2020)

Assessment of the Cardiovascular Risk Profile of Infants Exposed to Pre-eclampsia in-utero: A Prospective Case-Control Study in South African Children of African Ancestry
por: Nkeh-Chungag, Benedicta Ngwenchi, et al.
Publicado: (2021)

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment
por: Aamer, Hadega A., et al.
Publicado: (2020)

Assessment of the Performance of Obesity Measures in the Screening of Hypertension in a South African Adolescent Population
por: Engwa, Godwill Azeh, et al.
Publicado: (2023)

Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
por: Jacobs, Jana L., et al.
Publicado: (2019)

1564 Duration of Viral Suppression and objectively measured Antiretroviral Adherence as predictors of rebound Viremia in South Western Uganda
por: Musinguzi, Nicholas
Publicado: (2014)

Inflammation and salt in young adults: the African-PREDICT study
por: Crouch, Simone H., et al.
Publicado: (2020)

The paleobiology and paleoecology of South African Lystrosaurus
por: Botha, Jennifer
Publicado: (2020)

Antiretroviral therapy (ART) management of Low-Level Viremia in Taiwan (ALLEVIATE)
por: Cheng, Chien-Yu, et al.
Publicado: (2014)

Reduced adherence to antiretroviral therapy is associated with residual low-level viremia
por: Maggiolo, Franco, et al.
Publicado: (2017)

Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala
por: Ortíz, Dean W., et al.
Publicado: (2021)

Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy
por: Weissmann, Leonardo, et al.
Publicado: (2019)

Inflammation and hypertension development: A longitudinal analysis of the African-PREDICT study
por: Crouch, Simone H., et al.
Publicado: (2020)

Replicate Aptima Assay for Quantifying Residual Plasma Viremia in Individuals on Antiretroviral Therapy
por: Bakkour, Sonia, et al.
Publicado: (2020)

Automated Multireplicate Quantification of Persistent HIV-1 Viremia in Individuals on Antiretroviral Therapy
por: Jacobs, Jana L., et al.
Publicado: (2020)

Low-Level Viremia Is Associated With Cumulative Adherence to Antiretroviral Therapy in Persons With HIV
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2021)

Antiretroviral Refill Histories as a Predictor of Future Human Immunodeficiency Virus Viremia
por: Sokpa, Darryl, et al.
Publicado: (2022)

Cytomegalovirus Viremia as a Risk Factor for Mortality Prior to Antiretroviral Therapy among HIV-Infected Gold Miners in South Africa
por: Fielding, Katherine, et al.
Publicado: (2011)

Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain
por: Llibre, Josep M, et al.
Publicado: (2013)

The African Prospective study on the Early Detection and Identification of Cardiovascular disease and Hypertension (African-PREDICT): Design, recruitment and initial examination
por: Schutte, Aletta E, et al.
Publicado: (2019)

Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study
por: Hermans, Lucas E., et al.
Publicado: (2020)

Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa
por: Asare, Kwabena, et al.
Publicado: (2023)

Hepatitis C Viremia Patterns in Incident Hepatitis C Infection and One Year Later in 150 Prospectively Tested Persons Who Inject Drugs
por: Alanko Blomé, Marianne, et al.
Publicado: (2014)

2nd South Africa–United Kingdom cardiovascular workshop
por: Kelly-Laubscher, Roisin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_49ut2bvl5srpf6aavf5haef427